-
Inducing Labor at Term Appears to Reduce Cesarean Risk
drugs
August 09, 2018
Inducing labor at 39 weeks may decrease the risk of cesarean section, according to a study published in the Aug. 9 issue of the New England Journal of Medicine.
-
Samsung commits billions of dollars to building its biologics business
fiercepharma
August 09, 2018
Samsung has already spent billions of dollars in short order to establish one of the largest biologics manufacturing operations in the world. Today it said it will spend billions more.
-
FDA finds spiders and insects around packaging of Canadian API maker
fiercepharma
August 09, 2018
An FDA inspector didn’t have to spend long to discover that a Canadian API maker was failing to meet FDA standards for product testing, not to mention find insects and spiders in its packaging area.
-
Cyber Insurance Recommended for All Physician Practices
drugs
August 09, 2018
The growing threat of hacking is increasing the number of physicians buying cyber insurance, according to an article published in Medical Economics.
-
AI data miner Sensyne Health looks to go public with $77M listing
fiercebiotech
August 09, 2018
Digital health company Sensyne Health announced plans to go public with a £60 million listing ($77 million) on the alternative investment market of the London Stock Exchange on Aug. 17.
-
Credence MedSystems draws $12.8M to fund safety syringes
fiercebiotech
August 09, 2018
Credence MedSystems received a shot of $12.8 million in financing through a series B round. The funds will help advance and expand manufacturing of its injectable drug delivery devices.
-
Boston Scientific acquires remainder of vein stent maker Veniti in $160M deal
fiercebiotech
August 09, 2018
Boston Scientific plans to fully acquire stent developer Veniti—which it already owns 25% of—by buying up the remaining stake in the startup for $108 million upfront......
-
Agilent’s Keytruda PD-L1 assay expanded in Europe to cover first-line urothelial carcinoma
fiercebiotech
August 09, 2018
Agilent Technologies’ PD-L1 assay received an expanded label in Europe to help guide the use of first-line Keytruda in urothelial carcinoma. Physicians can now use the assay to help identify patients who are ineligible for cisplatin treatment and may resp
-
Most Antipsychotics Prescribed in Nursing Homes Initiated There
drugs
August 09, 2018
Antipsychotic therapy prescribed to nursing home residents is mostly initiated in nursing homes rather than hospitals or outpatient settings, according to a study published in the June issue of the Journal of the American Geriatrics Society.
-
Charles River Q2 revenues up 25%, buoyed by acquisitions and foreign currency rates
fiercebiotech
August 09, 2018
Charles River Labs reported that second-quarter revenues soared 24.8% to $585.3 million from $469.1 million a year ago on support from recent acquisitions and a favorable foreign currency environment.